Cognitive-Behavioral Therapy for the Treatment of Depression and Adherence in Patients With Type 1 Diabetes
Author(s) -
Sarah Markowitz,
Matthew M. Carper,
Jeffrey S. Gonzalez,
Linda M. Delahanty,
Steven A. Safren
Publication year - 2012
Publication title -
the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 50
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.11m01220
Subject(s) - medicine , depression (economics) , type 2 diabetes , diabetes mellitus , montgomery–åsberg depression rating scale , cognitive behavioral therapy , rating scale , physical therapy , major depressive disorder , psychiatry , anxiety , cognition , psychology , developmental psychology , economics , macroeconomics , endocrinology
Depression is one of the most common psychological problems affecting individuals with type 1 diabetes, and it is associated with treatment nonadherence and worse clinical outcomes. The research on treating depression or nonadherence in adults with type 1 diabetes is limited. We adapted an evidence-supported treatment, individual cognitive-behavioral therapy for adherence and depression (CBT-AD), for type 1 diabetes and examined its feasibility, acceptability, and potential for an effect.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom